Rivian Automotive, Inc.
16.005USD
-0.1650 (-1.02%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $-0.73▲ | $-0.77 | 4 | 5 |
| Next quarter | $-0.67▲ | $-0.69 | 4 | 7 |
| Current year | $-2.44▲ | $-2.7 | 11 | 1 |
| Next year | $-2.17▲ | $-2.38 | 9 | 3 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $-0.78 | $-0.63 | +0.15 (+18.9%) |
| 2026-03-31 | $-0.72 | $-0.33 | +0.39 (+53.9%) |
| 2025-12-31 | $-0.79 | $-0.66 | +0.13 (+16.7%) |
| 2025-09-30 | $-0.86 | $-0.96 | -0.10 (-11.1%) |
298 ratings from 29 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| RBC Capital | Maintained | Sector Perform | $14 $16 | Jul 31, 2026 |
| Morgan Stanley | Maintained | Underweight | $13 $14 | Jul 31, 2026 |
| TD Cowen | Maintained | Buy | $20 $21 | Jul 31, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $15 $16 | Jul 31, 2026 |
| Needham | Reiterated | Buy | $23 | Jul 31, 2026 |
| Cantor Fitzgerald | Reiterated | Neutral | $19 | Jul 28, 2026 |
| Piper Sandler | Upgraded from Neutral | Overweight | $18 $20 | Jul 27, 2026 |
| Morgan Stanley | Maintained | Underweight | $12 $13 | Jul 14, 2026 |
| UBS | Maintained | Neutral | $16 $17 | Jul 9, 2026 |
| BNP Paribas | Maintained | Outperform | $22 $24 | Jul 8, 2026 |
| Jefferies | Maintained | Hold | $16 $17 | Jul 7, 2026 |
| Needham | Reiterated | Buy | $23 | Jun 10, 2026 |
| TD Cowen | Reiterated | Buy | $20 | Jun 3, 2026 |
| DA Davidson | Maintained | Neutral | $14 $15 | May 11, 2026 |
| BNP Paribas | Reiterated | Outperform | $23 $22 | May 1, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $18 $19 | May 1, 2026 |
| Benchmark | Reiterated | Buy | $25 | May 1, 2026 |
| Needham | Reiterated | Buy | $23 | May 1, 2026 |
| Tigress Financial | Maintained | Buy | $25 | Apr 10, 2026 |
| Canaccord Genuity | Maintained | Buy | $22 | Apr 6, 2026 |
| DA Davidson | Upgraded from Underperform | Neutral | $14 | Apr 1, 2026 |
| Canaccord Genuity | Maintained | Buy | $21 $22 | Mar 20, 2026 |
| TD Cowen | Upgraded from Hold | Buy | $17 $20 | Mar 10, 2026 |
| Stifel | Maintained | Buy | $17 $20 | Feb 17, 2026 |
| DA Davidson | Downgraded from Neutral | Underperform | $15 $14 | Feb 17, 2026 |
112 filings from 12 insiders · 20 buy / 12 sell over 6m
Officers and directors of RIVN, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| MCDONOUGH CLAIREChief Financial Officer | Sell | 8.0k | $16.00 | $128k | Aug 20, 2026 |
| MCDONOUGH CLAIREChief Financial Officer | Sell | 13.1k | $14.50 | $191k | Aug 18, 2026 |
| KRAWIEC PETERDirector | Grant | 884 | — | — | Jul 20, 2026 |
| SCHWARTZ SANFORD HAROLDDirector | Grant | 1.2k | — | — | Jul 20, 2026 |
| KRAFCIK JOHNDirector | Grant | 1.2k | — | — | Jul 20, 2026 |
| GOMEZ AIDAN N.Director | Grant | 769 | — | — | Jul 20, 2026 |
| BOONE KARENDirector | Sellindirect | 20.0k | $20.00 | $400k | Jul 6, 2026 |
| FLATLEY JAY TDirector | Grant | 17.4k | — | — | Jun 22, 2026 |
| KRAWIEC PETERDirector | Grant | 17.4k | — | — | Jun 22, 2026 |
| SCHWARTZ SANFORD HAROLDDirector | Grant | 17.4k | — | — | Jun 22, 2026 |
| BOONE KARENDirector | Grant | 17.4k | — | — | Jun 22, 2026 |
| KRAFCIK JOHNDirector | Grant | 17.4k | — | — | Jun 22, 2026 |
| GOMEZ AIDAN N.Director | Grant | 17.4k | — | — | Jun 22, 2026 |
| MCDONOUGH CLAIREChief Financial Officer | Sell | 8.0k | $18.00 | $144k | Jun 3, 2026 |
| MCDONOUGH CLAIREChief Financial Officer | Sell | 8.0k | $16.00 | $128k | May 29, 2026 |
| SCARINGE ROBERT JChief Executive Officer | Sell | 34.8k | $15.00 | $522k | May 28, 2026 |
| MCDONOUGH CLAIREChief Financial Officer | Sell | 7.6k | $14.00 | $106k | May 21, 2026 |
| CALLAHAN MICHAEL JOHNOfficer | Grant | 1.7k | $11.67 | $20k | May 20, 2026 |
| VENKATARATNAM SREELAOfficer | Grant | 2.8k | $11.67 | $32k | May 20, 2026 |
| MCDONOUGH CLAIREChief Financial Officer | Sell | 5.5k | $13.43 | $74k | May 18, 2026 |
No analyst notes on RIVN yet.
Analyst Ratings
26 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 5 | 7 | 8 | 3 | 2 | Hold2.60 |
| 1 mo ago | 5 | 7 | 8 | 3 | 2 | Hold2.60 |
| 2 mo ago | 5 | 7 | 8 | 3 | 2 | Hold2.60 |
| 3 mo ago | 3 | 8 | 10 | 3 | 2 | Hold2.73 |